CLBT Cellebrite DI Ltd.

BULLISH Impact: 6/10 6-K
Horizon weeks Filed May 14, 2026 Processed 26d 19h ago SEC 0001213900-26-056220
Notable filing: 6-K
Latest settled — T+5d
CLBT ▲ +0.38% at T+5d
LONG call ✓ call won +0.38% · α vs SPY +1.10% · entry $13.12 → $13.17
Next anchor: T+20d in 2d
Last close $13.43 (close Jun 8) · +2.36% from $13.12 entry
Entry anchored
May 13, 03:59 PM ET
via Databento tick
T+1d
-1.07%
call -1.07% · α +0.16%
$12.98
settled 26d ago
T+5d
+0.38%
call +0.38% · α +1.10%
$13.17
settled 20d ago
T+20d
call — · α —
in 2d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Cellebrite reported Q1 2026 revenue of $128.3M (+19% YoY) and ARR of $493M (+21%), with non-GAAP EPS of $0.12 vs $0.10 a year ago. Subscription revenue grew 23% to $117.9M, and dollar-based net retention remained strong at 115%. Guidance for Q2 ARR of $510-513M implies 22-23% growth, and full-year ARR of $567-573M implies 18-19% growth, signaling continued momentum.

Actionable Insight

The strong ARR growth and raised Q2 guidance suggest accelerating demand. Traders should watch for continued subscription strength and potential upside from new products (Genesis, Guardian Investigate) and FedRAMP authorization expanding government sales.

Key Facts

  • Revenue of $128.3M, up 19% YoY
  • ARR of $493.0M, up 21% YoY
  • Non-GAAP diluted EPS of $0.12 vs $0.10 YoY
  • Q2 ARR guidance: $510M-$513M (22-23% growth)
  • Full-year ARR guidance: $567M-$573M (18-19% growth)

Financial Impact

Revenue grew 19% YoY to $128.3M, with subscription revenue up 23% to $117.9M. Non-GAAP net income rose 17% to $30.6M.

revenuearrnon-gaap eps

Risk Factors

  • GAAP net income declined to $10.9M from $17.4M due to higher operating expenses
  • Dependence on law enforcement budgets and geopolitical risks from Israeli operations

Market Snapshot

Exchange
Nasdaq
Sector
Services-Prepackaged Software
Analyst Consensus
92% bullish (13 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-056220
Document: ea0290724-6k_cellebrite.htm0001213900-26-056220
Document: 0001213900-26-056220-index-headers.html0001213900-26-056220
Document: 0001213900-26-056220-index.html0001213900-26-056220
Document: 0001213900-26-056220.txt0001213900-26-056220
4 reports for CLBT
Performance horizon
Filters
Rows
Reports for CLBT — sortable, filterable
Type Now
May 19, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$13.46 $12.79▼ −5.01%▼ −7.26%$13.43 (−0.22%)
May 14, 2026
26d ago
6-K
BULLISH ★ 6/10
$13.12 $13.17▲ +0.38%▲ +1.10%$13.43 (+2.36%)
May 12, 2026
28d ago
144
NEUTRAL ★ 1/10
$12.10 $13.46▲ +11.24%▲ +12.40%$13.43 (+10.99%)
May 12, 2026
28d ago
144
NEUTRAL ★ 1/10
$12.10 $13.46▲ +11.24%▲ +12.40%$13.43 (+10.99%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 7h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access